Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 16488.02 -10.70 NIFTY 4895.10 -3.30
 

Glenmark Pharma Yearly Results, Glenmark Pharma Financial Statement & Accounts

Glenmark Pharma

BSE: 532296  |  NSE: GLENMARK  |  ISIN: INE935A01035  |  Pharmaceuticals

Notes To The Accounts
Print/Copy to Excel :
« Previous Years  

Yearly Results of Glenmark Pharma

------------------- in Rs. Cr. -------------------
Mar '05 Mar '06 Mar '07 Mar '08 Mar '09
Sales Turnover 493.75 562.94 802.64 1,372.69 856.11
Other Income 5.49 5.31 6.26 20.05 98.68
Total Income 499.23 568.25 808.90 1,392.74 954.78
Total Expenses 380.58 459.65 591.38 890.98 634.17
Operating Profit 113.17 103.29 211.26 481.71 221.94
Profit On Sale Of Assets -- -- -- -- --
Profit On Sale Of Investments -- -- -- -- --
Gain/Loss On Foreign Exchange -- -- -- -- --
VRS Adjustment -- -- -- -- --
Other Extraordinary Income/Expenses -- -- -- -- --
Total Extraordinary Income/Expenses -- -- -- -- -0.30
Tax On Extraordinary Items -- -- -- -- --
Net Extra Ordinary Income/Expenses -- -- -- -- --
Gross Profit 118.66 108.60 217.52 501.76 320.62
Interest 16.73 5.82 22.95 41.13 55.14
PBDT 101.91 102.79 194.57 460.63 265.19
Depreciation 14.98 17.49 23.46 29.44 19.11
Depreciation On Revaluation Of Assets -- -- -- -- --
PBT 86.93 85.30 171.11 431.19 246.08
Tax 23.45 18.00 36.31 42.17 28.15
Net Profit 63.48 67.30 134.80 389.02 217.93
Prior Years Income/Expenses -- -- -- -- --
Depreciation for Previous Years Written Back/ Provided -- -- -- -- --
Dividend -- -- -- -- --
Dividend Tax -- -- -- -- --
Dividend (%) -- -- -- -- --
Earnings Per Share 5.35 28.35 11.23 31.28 8.70
Book Value -- -- -- -- --
Equity 23.72 23.74 24.01 24.87 25.05
Reserves 240.16 271.31 426.15 1,003.38 1,204.92
Face Value 2.00 10.00 2.00 2.00 1.00
Source : Religare Technova
Explore Glenmark connections